Hepatic Resection Improved the Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma in Asia: a Systematic Review and Meta-Analysis (Q38460881)

From Wikidata

Jump to navigation Jump to search

scientific article published on 06 May 2015

Language	Label	Description	Also known as
English	Hepatic Resection Improved the Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma in Asia: a Systematic Review and Meta-Analysis	scientific article published on 06 May 2015

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

0 references

1 reference

Europe PubMed Central

Hepatic Resection Improved the Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma in Asia: a Systematic Review and Meta-Analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

systematic review

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Wei Liu

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Jian-Guo Zhou

2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Yi Sun

3

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Lei Zhang

4

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Bao-Cai Xing

5

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

6 May 2015

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Journal of Gastrointestinal Surgery

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

1271-1280

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

https://scigraph.springernature.com/pub.10.1007/s11605-015-2811-6

0 references

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

Hepatocellular carcinoma in the Asia pacific region

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

Prognosis of hepatocellular carcinoma: the BCLC staging classification

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

Current status of radiofrequency ablation of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

Management of hepatocellular carcinoma: An update

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

Prospective validation of the Barcelona Clinic Liver Cancer staging system

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

Is liver resection justified in advanced hepatocellular carcinoma? Results of an observational study in 464 patients.

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

Practical methods for incorporating summary time-to-event data into meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

Liver resection improves the survival of patients with multiple hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

Surgery versus transarterial chemoembolization for solitary large hepatocellular carcinoma of BCLC stage A.

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

Barcelona clinic liver cancer stage B hepatocellular carcinoma: transarterial chemoembolization or hepatic resection?

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

Comparing hepatic resection and transarterial chemoembolization for Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma: change for treatment of choice?

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma - Survival analysis of 3892 patients

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

Hepatic resection is safe and effective for patients with hepatocellular carcinoma and portal hypertension

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design.

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved?

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

Liver Cancer Working Group report.

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

Prospective validation of the Chinese University Prognostic Index and comparison with other staging systems for hepatocellular carcinoma in an Asian population.

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies.

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

Is there any difference in survival according to the portal tumor thrombectomy method in patients with hepatocellular carcinoma?

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

Therapeutic options for intermediate-advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

Prognostic factors after liver resection for hepatocellular carcinoma: a single-center experience from China

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

Postoperative adjuvant transarterial chemoembolization for participants with hepatocellular carcinoma: A meta-analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

A meta-analysis and systematic review: adjuvant interferon therapy for patients with viral hepatitis-related hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

Antiviral therapy for adults with chronic hepatitis B: a systematic review for a National Institutes of Health Consensus Development Conference

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

The intermediate hepatocellular carcinoma stage: Should treatment be expanded?

1 reference

https://api.crossref.org/works/10.1007%2FS11605-015-2811-6

21 January 2018

A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25943910

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions

1 reference

https://pubmed.ncbi.nlm.nih.gov/25943910

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25943910

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Building the multidisciplinary team for management of patients with hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25943910

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One Thousand Fifty-Six Hepatectomies Without Mortality in 8 Years

1 reference

https://pubmed.ncbi.nlm.nih.gov/25943910

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medium-sized (3.1-5.0 cm) hepatocellular carcinoma: transarterial chemoembolization plus radiofrequency ablation versus radiofrequency ablation alone

1 reference

https://pubmed.ncbi.nlm.nih.gov/25943910

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of surgical resection and transarterial chemoembolization for hepatocellular carcinoma beyond the Milan criteria: a propensity score analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25943910

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of mesohepatectomy with or without transcatheter arterial chemoembolization for large centrally located hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25943910

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade

1 reference

https://pubmed.ncbi.nlm.nih.gov/25943910

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TACE vs. surgical resection for BCLC stage B HCC

1 reference

https://pubmed.ncbi.nlm.nih.gov/25943910

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rationality and effectiveness of transarterial chemoembolization as an initial treatment for BCLC B stage HBV-related hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25943910

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database

1 reference

https://pubmed.ncbi.nlm.nih.gov/25943910

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan Criteria: a RCT

1 reference

https://pubmed.ncbi.nlm.nih.gov/25943910

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of transarterial chemoembolization before liver resection for hepatocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25943910

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11605-015-2811-6

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38460881&oldid=1760876635"